MedTrace Logo

Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer

NCT03819088 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2025-10-09

No results posted yet for this study

Summary

This randomized study examines how well zinc works in improving quality of life in patients with gastrointestinal cancer that cannot be removed by surgery who are receiving chemotherapy. Zinc may help to improve patient's quality of life by preventing zinc deficiency.

Conditions

  • Gastric Carcinoma
  • Liver and Intrahepatic Bile Duct Carcinoma
  • Unresectable Esophageal Carcinoma
  • Unresectable Pancreatic Carcinoma

Interventions

DIETARY_SUPPLEMENT

Zinc

Given PO

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • Emory University

    lead OTHER

Principal Investigators

  • Olatunji B. Alese, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-17
Primary Completion
2021-10-05
Completion
2022-03-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03819088 on ClinicalTrials.gov